M&T Bank Corp Bristol Myers Squibb CO Transaction History

M&T Bank Corp

$29.1 Billion
Q2 2024

A detailed history of M&T Bank Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, M&T Bank Corp holds 943,470 shares of BMY stock, worth $48 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

943,470

Previous 1,011,106 6.69%

Holding current value

$48 Million

Previous $54.8 Million 28.54%

% of portfolio

0.13%

Previous 0.19%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$40.25 - $52.99 $2.72 Million - $3.58 Million	-67,636 Reduced 6.69%	943,470 $39.2 Million
Q1 2024 May 07, 2024	SELL	$47.98 - $54.4 $2.52 Million - $2.86 Million	-52,543 Reduced 4.94%	1,011,106 $54.8 Million
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $16.7 Million - $19.9 Million	-344,568 Reduced 24.47%	1,063,649 $54.6 Million
Q3 2023 Nov 02, 2023	SELL	$57.89 - $64.73 $3.02 Million - $3.38 Million	-52,147 Reduced 3.57%	1,408,217 $81.7 Million
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $1.3 Million - $1.44 Million	-20,336 Reduced 1.37%	1,460,364 $93.4 Million
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $1.04 Million - $1.18 Million	-15,832 Reduced 1.06%	1,480,700 $103 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $1.95 Million - $2.31 Million	28,430 Added 1.93%	1,503,531 $108 Million
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $479,291 - $567,548	-6,999 Reduced 0.47%	1,496,532 $108 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $6,878 - $4.07 Million	52,913 Added 3.72%	1,475,101 $104 Million
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $4 Million - $4.41 Million	55,101 Added 4.03%	1,422,188 $105 Million
Q1 2022 May 09, 2022	BUY	$61.48 - $73.72 $1.9 Million - $2.28 Million	30,881 Added 2.31%	1,367,087 $99.8 Million
Q4 2021 Feb 07, 2022	SELL	$53.63 - $62.52 $1.78 Million - $2.08 Million	-33,249 Reduced 2.43%	1,336,206 $83.3 Million
Q3 2021 Oct 28, 2021	SELL	$59.17 - $69.31 $4.28 Million - $5.01 Million	-72,256 Reduced 5.01%	1,369,455 $81 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $3.93 Million - $4.28 Million	-63,453 Reduced 4.22%	1,441,711 $96.3 Million
Q1 2021 May 06, 2021	SELL	$59.34 - $66.74 $5.1 Million - $5.74 Million	-85,992 Reduced 5.4%	1,505,164 $95 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $1.32 Million - $1.49 Million	-22,798 Reduced 1.41%	1,591,156 $98.7 Million
Q3 2020 Nov 06, 2020	SELL	$57.43 - $63.64 $828,485 - $918,070	-14,426 Reduced 0.89%	1,613,954 $96.3 Million
Q2 2020 Jul 29, 2020	SELL	$54.82 - $64.09 $1.15 Million - $1.34 Million	-20,927 Reduced 1.27%	1,628,380 $94.8 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $6.06 Million - $8.81 Million	-130,645 Reduced 7.34%	1,649,307 $91 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $9.33 Million - $12.2 Million	189,654 Added 11.93%	1,779,952 $108 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $255,422 - $302,840	-5,972 Reduced 0.37%	1,590,298 $80.6 Million
Q2 2019 Aug 12, 2019	BUY	$44.62 - $49.34 $17.7 Million - $19.6 Million	396,703 Added 33.07%	1,596,270 $72.4 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $1.44 Million - $1.72 Million	-31,901 Reduced 2.59%	1,199,567 $57.2 Million
Q4 2018 Feb 01, 2019	SELL	$48.76 - $63.23 $3.08 Million - $4 Million	-63,190 Reduced 4.88%	1,231,468 $64 Million
Q3 2018 Nov 09, 2018	BUY	$55.19 - $62.25 $368,117 - $415,207	6,670 Added 0.52%	1,294,658 $80.4 Million
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $19.2 Million - $24 Million	-380,505 Reduced 22.81%	1,287,988 $71.3 Million
Q1 2018 May 04, 2018	SELL	$59.92 - $68.98 $281,923 - $324,550	-4,705 Reduced 0.28%	1,668,493 $106 Million
Q4 2017 Feb 06, 2018	SELL	$59.94 - $65.35 $642,376 - $700,355	-10,717 Reduced 0.64%	1,673,198 $103 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $194,464 - $224,428	3,521 Added 0.21%	1,683,915 $107 Million
Q2 2017 Aug 11, 2017	BUY	N/A	1,680,394	1,680,394 $93.6 Million

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account